Temaril-P for Dogs: Uses, Dosing, and Cautions

By Dr. Zubair Khalid, DVM, MS, PhD ·

Temaril-P for Dogs: Uses, Dosing, and Cautions

The Direct Answer

Temaril-P is a prescription veterinary tablet that combines two active drugs in one product: trimeprazine tartrate, an antihistamine-type agent, and prednisolone, a corticosteroid. The U.S. label indication is the relief of itching (pruritus) associated with allergic and inflammatory skin conditions and the treatment of cough associated with inflammatory conditions of the respiratory tract in dogs [1]. It is given by mouth, usually once or twice daily at first, and then reduced over days to weeks under veterinary direction. Because it contains a corticosteroid, Temaril-P is not a casual itch pill. It can cause increased thirst, increased urination, increased appetite, weight gain, and a higher risk of infection, and it must be tapered rather than stopped abruptly after long use [1]. It is not for use in cats unless a veterinarian has specifically directed it, and it is not for dogs with viral infections, pregnant dogs, or dogs with corneal ulcers [1].

This article is educational and is not a substitute for veterinary diagnosis or treatment.

At a Glance

FeatureDetail
Active ingredientsTrimeprazine tartrate (antihistamine) plus prednisolone (corticosteroid)
SpeciesDogs (label product)
Typical usePruritus from allergic and inflammatory skin disease, inflammatory cough
How it is givenBy mouth as a tablet or capsule
How fast it worksAntipruritic corticosteroids act within hours in experimental models, though clinical response in an individual dog varies [2]
Prescription statusPrescription only, dispensed by a veterinarian
Main cautionsCorticosteroid effects, infection risk, contraindicated in viral infection, pregnancy, and corneal ulcers
Stopping the drugTaper as directed. Never stop abruptly after long-term use

What Temaril-P Actually Is

Temaril-P is a fixed-combination product. One part, trimeprazine tartrate, belongs to the phenothiazine family and behaves like an antihistamine with some sedative and antipruritic activity. The other part, prednisolone, is a glucocorticoid, the same class of drug used throughout veterinary medicine to suppress inflammation and itching. The manufacturer combines them so that a single tablet delivers both a modest antihistamine effect and a corticosteroid effect [1].

That combination matters to owners. Many over-the-counter itch products for dogs contain antihistamines alone. Temaril-P is different because the prednisolone component carries the full set of corticosteroid responsibilities. A dog on Temaril-P is, in practical terms, a dog on a steroid, and everything that follows in this article flows from that fact.

Prednisolone itself is one of the better-studied antipruritic drugs in dogs. In a blinded, placebo-controlled laboratory model using interleukin-31 to provoke itch, prednisolone given orally at 0.5 mg per kilogram reduced induced scratching when it was administered about ten hours before the observation period [2]. The same study showed that when the drug was given only one hour before testing, oral prednisolone at 0.25 or 0.5 mg per kilogram did not significantly reduce itch, while injectable dexamethasone did [2]. The practical takeaway is not that prednisolone fails, but that the timing and cumulative exposure matter. Corticosteroids work, and they work best when they are given consistently and correctly rather than erratically.

How the Two Ingredients Work

Trimeprazine tartrate blocks histamine at receptor sites and produces sedation in many dogs. That sedation is sometimes useful, because a chronically itchy dog sleeps poorly, and sometimes it is the side effect owners notice first. Histamine is only one of many itch mediators in canine allergic skin disease, which is why antihistamines used alone often disappoint in dogs with atopic dermatitis. Antihistamines tend to work better for urticaria (hives) and for mild, histamine-driven itch than for the complex, cytokine-driven itch of chronic allergic dermatitis.

Prednisolone works differently. It enters the cell, binds the glucocorticoid receptor, and changes how genes involved in inflammation are transcribed. The downstream effect is broad suppression of inflammatory cells and mediators, which is why corticosteroids reduce itching, redness, swelling, and airway inflammation across many conditions. Canine itch research has repeatedly demonstrated that corticosteroids like prednisolone reduce pruritic behavior in controlled models [2]. Comparative studies in dogs with atopic dermatitis have shown that prednisolone at 0.5 mg per kilogram once daily reduces clinical lesion scores and owner-assessed pruritus to a degree comparable to immunomodulators like cyclosporine over a six-week trial [3].

The combination is not a cure for allergy. It is a control tool. It reduces the itch and inflammation while the veterinarian works on the underlying cause, whether that cause is environmental allergy, food allergy, contact irritation, or an inflammatory airway problem.

Labeled Uses

According to the product label as summarized in veterinary client-education material, Temaril-P is indicated for two categories of problems in dogs [1]:

  1. Pruritus associated with allergic and inflammatory skin conditions.
  2. Cough associated with inflammatory conditions of the respiratory tract.

The first indication covers a wide range of itchy skin disease: atopic dermatitis, flea allergy dermatitis, contact dermatitis, and other inflammatory dermatoses. The second covers coughing driven by airway inflammation, such as inflammatory bronchitis, where suppressing the inflammatory component reduces the cough. The label pairing of trimeprazine with prednisolone was designed so the antihistamine supports the antipruritic and antitussive effect while the steroid does the heavy anti-inflammatory work.

What Temaril-P Does Not Cover

Temaril-P does not treat infection. It suppresses inflammation, and suppression of inflammation can mask or worsen an infection that is driving the itching. A dog with a bacterial pyoderma, a yeast overgrowth, or a fungal infection needs that infection addressed. Steroids given to an infected dog without antimicrobial coverage can allow the infection to spread. This is one of the reasons veterinarians examine the skin and sometimes perform cytology or skin scrapings before prescribing it.

Temaril-P also does not diagnose or cure allergy. It controls signs. If the underlying trigger is not identified and managed, the dog will itch again as soon as the drug is withdrawn, and repeated steroid courses accumulate risk.

Dosing: What the Label States

Doses for Temaril-P come from the label. Dosing is individualized by the prescribing veterinarian, and the exact tablet strength and tablet count vary with the dog's weight and the product size dispensed. The label describes an initial dose given on a tapering schedule that steps down in frequency over a period of days, reflecting the corticosteroid component [1].

Label-Sourced Dosing Schedule

IndicationDose basisInitial frequencyTaperMonitoring
Pruritus from allergic or inflammatory skin diseaseAs directed by the label, often calculated by body weight and individual responseUsually once or twice daily at the startReduce frequency on a stepwise schedule over days, then to the lowest effective frequency or discontinuationItch score, thirst, urination, appetite, weight, skin condition
Cough from inflammatory respiratory diseaseAs directed by the label, often calculated by body weightUsually once or twice daily at the startSame stepwise frequency reduction, guided by cough controlCough frequency, thirst, urination, appetite, weight

The pattern the label follows is straightforward: start at the effective frequency, then reduce the number of doses per day in steps rather than stopping suddenly [1]. The reason for the taper is the prednisolone. A dog whose adrenal glands have been suppressed by weeks of corticosteroid exposure may not resume normal cortisol production immediately when the drug vanishes. Tapering lets the body ramp its own cortisol production back up.

How to Give It

Give Temaril-P exactly as prescribed. A few practical rules reduce problems:

  • Give with food if the dog vomits or develops stomach upset.
  • Give at the same times each day to keep blood levels steady.
  • Do not double up a missed dose. If a dose is missed, give it when you remember unless it is nearly time for the next dose, then resume the normal schedule.
  • Do not split tablets unless the veterinarian or pharmacist says the tablet can be split.
  • Keep a written log of doses, itch scores, water intake, and urination. Veterinarians use that information to guide the taper.

Never Adjust the Dose on Your Own

The single most common error owners make with corticosteroid combination products is improvising. They give an extra tablet because the dog had a bad itch night. They stop cold because the dog seems better. Both moves create problems. The first pushes the dog toward steroid side effects. The second can trigger a rebound flare of itching or, after long use, a physiologic problem from abrupt withdrawal of corticosteroid support. Follow the printed schedule and call the clinic if it is not working.

Side Effects: What Corticosteroids Do

Because Temaril-P contains prednisolone, its side effect profile is dominated by corticosteroid effects. Owners should expect to see some of these, especially at higher starting doses, and should report anything severe.

The Expected Corticosteroid Cluster

  • Polyuria (increased urination)
  • Polydipsia (increased thirst)
  • Polyphagia (increased appetite)
  • Weight gain

These four signs form the classic corticosteroid cluster. They are dose-dependent and often improve as the dose is tapered. In a controlled trial of combined prednisolone and oclacitinib therapy in dogs with atopic dermatitis, polyuria and polydipsia occurred in two dogs and polyphagia in three dogs during the prednisolone phase, and all resolved by day 14 [4]. That study used prednisolone at 0.5 mg per kilogram, a dose in the range used for inflammatory skin and airway disease, and it confirms two things: these effects are real, and they commonly fade when the steroid exposure is reduced [4].

Weight gain deserves separate attention. A dog that suddenly eats everything in sight and gains weight on prednisolone is showing a drug effect, not a personality change. Owners should resist the urge to free-feed, measure portions, and tell the veterinarian if weight is climbing.

Other Reported Effects

Corticosteroids can cause panting, restlessness, and occasionally GI upset. Trimeprazine can cause sedation and, less commonly, excitement or behavioral change. In the same combined-therapy trial, one dog in the oclacitinib-only group developed self-limiting vomiting, and mild liver enzyme increases were seen in a small number of dogs [4]. Those liver changes were mild and did not force withdrawal in that study population, but they are the reason veterinarians periodically check bloodwork during longer steroid courses.

Infection Risk

Corticosteroids suppress immune function and inflammation. That combination can allow bacterial skin infections to establish or worsen, can reactivate latent infections, and can blunt the signs that would normally tell you an infection is present. A dog on Temaril-P that develops new areas of redness, pustules, odor, or worsening itch may have an infection layered on top of the allergy. Call the clinic rather than increasing the dose.

What to Do About Side Effects

Mild increased thirst, urination, and appetite are expected and usually manageable. Report them so the veterinarian can factor them into the taper. Report immediately:

  • Vomiting or diarrhea that persists
  • Refusal to eat
  • Marked lethargy
  • Blood in vomit or stool
  • Black, tarry stool
  • New skin lesions, pustules, or a bad odor
  • Collapse, weakness, or a distended abdomen
  • Any sign the dog is drinking or urinating so much that accidents or dehydration occur

Do not stop the drug on your own if a serious side effect appears. Call the veterinarian, who will advise whether to taper faster, switch drugs, or bring the dog in.

Who Should Not Receive Temaril-P

The label lists specific contraindications and warnings that owners need to know before the first dose [1]:

  • Viral infections. Corticosteroids can worsen viral disease. A dog with a known active viral infection should not receive this product.
  • Pregnancy. The product is not for use in pregnant dogs.
  • Corneal ulcers. The product is contraindicated in animals with corneal ulcers. If a dog has a red, painful, squinting eye with a cloudy or ulcerated surface, tell the veterinarian before starting or continuing Temaril-P.
  • Dogs with other serious systemic conditions may also be poor candidates. Corticosteroids can worsen diabetes, heart failure, hypertension, and certain infections and can interact with other drugs.

Beyond the label, veterinarians commonly avoid or use corticosteroids with extra caution in dogs with a history of stomach ulcers, kidney disease, uncontrolled diabetes, or immune suppression. Discuss the full medical history every time the prescription is renewed.

Drug Interactions and Combination Therapy

The corticosteroid component interacts with other drugs. Vaccines, other steroids, nonsteroidal anti-inflammatory drugs, diabetes medications, diuretics, and some antibiotics can all interact with prednisolone. Give the veterinarian a complete list of everything the dog takes, including supplements and joint chews.

Combining prednisolone with modern antipruritic drugs is not unusual. A 2025 controlled trial compared alternate-day prednisolone and oclacitinib against oclacitinib alone in dogs with atopic dermatitis and found both strategies reduced pruritus and lesion scores significantly by day 7, with no significant difference between groups through day 60 [4]. That study is important for owners because it shows that a short, well-managed corticosteroid course can be a bridge while a nonsteroidal antipruritic takes effect, and that the combination is tolerable when monitored [4].

Owners also ask about newer options. Oclacitinib produces rapid itch relief, often within 24 hours in controlled trials, by inhibiting Janus kinase dependent cytokines [5]. Injectable lokivetmab reduced pruritus in a dose-dependent fashion for weeks in dogs with atopic dermatitis [6]. A newer anti-IL-31 monoclonal antibody approach has also shown meaningful reductions in itch scores in controlled models [7]. None of those drugs replace the need to identify and manage the underlying cause, and none of them are interchangeable with Temaril-P. They are alternatives a veterinarian may choose to reduce steroid exposure.

Pruritus is also measurable, which helps guide therapy. The pruritus Visual Analog Scale is validated in dogs, and a simpler 0 to 10 verbal numeric scale correlates well with it and responds to treatment [8]. Owners who score their dog's itch at every recheck give the veterinarian objective data for deciding how fast to taper Temaril-P.

Temaril-P Compared With the Main Alternatives

A fair comparison starts with what Temaril-P is: a steroid-based combination product for short-to-medium term control of itching and inflammatory cough. Its strengths are rapid anti-inflammatory action and low cost relative to many newer drugs. Its weaknesses are the corticosteroid side effects and the need for tapering.

Nonsteroidal antipruritics such as oclacitinib offer itch control without the classic steroid cluster of increased thirst, urination, and appetite. Controlled trials show a rapid onset of effect, with significant improvement in owner-assessed pruritus within a day of starting treatment [5]. Newer anti-IL-31 biologics can provide weeks of relief from a single injection [7][6].

Immunomodulators such as cyclosporine reduce lesion severity and pruritus over weeks. A blinded trial comparing cyclosporine with prednisolone in atopic dogs found both reduced lesion and itch scores significantly by six weeks, with comparable tolerability [3].

Antihistamines used alone are generally weaker for chronic allergic itch. The reason is visible in the pharmacology. Canine atopic itch involves cytokines such as interleukin-31, which drive scratching through pathways that antihistamines do not block [9][10]. Corticosteroids and cytokine-targeted drugs act further down that chain.

Where Temaril-P still fits: acute flares, short bridge courses while other drugs load, inflammatory cough, and situations where an owner cannot manage injections or the cost of newer drugs. The choice belongs to the veterinarian who has examined the dog.

Owner Monitoring: A Practical Checklist

Monitoring is the difference between safe use and complications. Do the following while your dog is on Temaril-P:

  1. Track daily water intake roughly by bowl refills and note any dramatic increase.
  2. Track urination, including accidents in the house or increased overnight needs.
  3. Track appetite and do not free-feed. Measure food.
  4. Weigh your dog weekly if you can, and report changes.
  5. Score itching daily on a 0 to 10 scale and write it down [8].
  6. Photograph any skin change, new redness, pustules, or hair loss.
  7. Note any vomiting, diarrhea, lethargy, or behavior change.
  8. Bring the log to every recheck.
  9. Follow the taper exactly as written.
  10. Call the clinic before changing anything.

Owners who keep this log make their veterinarian's job easier and their dog's taper smoother. Poorly controlled pruritus and complex regimens also increase caregiver burden and can strain the owner-veterinarian relationship, so a clear, written plan and simple tracking help both sides [11].

Tapering Off Temaril-P

The taper is not optional. After more than a few days of corticosteroid exposure, the adrenal glands reduce their own cortisol output. Stopping suddenly removes the external steroid, and the body may be temporarily unable to produce enough of its own. The label schedule steps the dose frequency down rather than stopping at once [1].

A typical taper reduces the number of daily doses in stages. The veterinarian may drop from twice daily to once daily, then to every other day, then to twice weekly, then stop. The exact steps and the speed depend on how long the dog has been on the drug, the dose, the response, and the underlying disease. If itching returns during the taper, tell the veterinarian. The answer is usually to hold at the current step or add a nonsteroidal antipruritic, not to jump back to the starting dose indefinitely.

Some dogs need long-term low-dose corticosteroid therapy because their disease cannot be controlled another way. Those dogs require periodic bloodwork, weight checks, and reassessment of infection risk. The goal is always the lowest dose that controls signs for the shortest necessary time.

Limitations and When to Contact a Veterinarian

Temaril-P is a prescription drug and every dog's situation differs. No article replaces an examination, a diagnosis, and a treatment plan from the dog's own veterinarian.

Contact a veterinarian promptly if any of the following occur:

  • The dog stops eating or starts vomiting repeatedly
  • Diarrhea persists beyond a day
  • There is blood in vomit or stool, or the stool turns black and tarry
  • The dog becomes weak, collapses, or seems disoriented
  • The abdomen looks distended or the dog is panting heavily at rest
  • New skin lesions, pustules, or a foul odor develop
  • The dog develops eye pain, squinting, or cloudiness (possible corneal ulcer)
  • The dog is drinking or urinating so much that dehydration or accidents become a daily problem
  • Itching is worse despite treatment
  • You cannot complete the prescribed taper because signs flare

Go to an emergency clinic for collapse, severe vomiting, bloody diarrhea, difficulty breathing, or a painful, suddenly cloudy eye. Do not wait for a routine appointment.

Frequently Asked Questions

What is Temaril-P used for in dogs?

Temaril-P treats itching from allergic and inflammatory skin conditions and cough from inflammatory respiratory conditions in dogs. It combines trimeprazine tartrate with prednisolone and is available only by prescription [1].

Can I stop Temaril-P suddenly?

No. After long use, the drug must be tapered as directed because of the corticosteroid component. Abrupt withdrawal can cause a flare or a physiologic problem from suppressed adrenal function [1].

What are the most common side effects?

Increased thirst, increased urination, increased appetite, and weight gain are the most common effects. They are dose-related and often improve as the dose is reduced [4].

Is Temaril-P safe for cats?

The product is a dog product. Do not give it to a cat unless the prescribing veterinarian has specifically directed it after examining the cat.

Can Temaril-P be given to a pregnant dog?

No. Pregnancy is listed among the contraindications for the product [1].

What if my dog has an eye problem while on Temaril-P?

Tell the veterinarian before giving the next dose. Corneal ulcers are a contraindication for this product, and steroid-containing products can worsen certain eye conditions [1].

How fast should I expect improvement?

Corticosteroids act within hours in controlled models, and many dogs improve within the first days of treatment [2]. If there is no improvement or signs worsen, call the veterinarian.

Can Temaril-P be combined with other itch medications?

Sometimes. A controlled trial found alternate-day prednisolone combined with oclacitinib controlled atopic dermatitis signs comparably to oclacitinib alone over eight weeks [4]. Any combination must be directed and monitored by a veterinarian.

Related Articles

Sources

  1. Trimeprazine Tartrate - Prednisolone (Temaril-P) - Veterinary Partner - VIN
  2. IL-31-induced pruritus in dogs: a novel experimental model to evaluate anti-pruritic effects of canine therapeutics
  3. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial.
  4. Evaluation of oclacitinib maleate and prednisolone combined therapy for the control of atopic dermatitis in dogs: A controlled clinical trial.
  5. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis
  6. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.
  7. Onset and duration of action of lokivetmab in a canine model of IL-31 induced pruritus
  8. Validation of the 0-10 verbal numeric scale for assessment of pruritus severity in dogs.
  9. Establishment of an Intradermal Canine IL-31-Induced Pruritus Model to Evaluate Therapeutic Candidates in Atopic Dermatitis
  10. Characterisation of the pruritus responses and pruritic behaviours in an interleukin 31-induced canine model of pruritus.
  11. Assessment of owner perceptions of caregiver burden, veterinarian-client relationship and satisfaction with the provider in canine pruritus: An experimental vignette study.